Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency

Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency

US Patent 11890289 · Granted Feb 6, 2024

Estimated economic value: $29,465,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for shrinking pituitary tumors2025
Methods for imaging and treatment of somatostatin-receptor positive tumors2025
Methods of treating neuroepithelial tumors using selective glucocorticoid recept2025
Fatty liver disease treatment using glucocorticoid and mineralocorticoid recepto2025
Intermittent dosing of glucocorticoid receptor modulators for the treatment of o2024
Treatment of hypercoagulopathy in Cushing's syndrome by administration of glucoc2024
Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocort2024
Concomitant administration of glucocorticoid receptor modulators and CYP3A inhib2024
Methods for shrinking pituitary tumors2024
Concomitant administration of glucocorticoid receptor modulators and CYP3A inhib2024
Methods of treating antipsychotic-induced weight gain with miricorilant2024
Methods of treating neuroepithelial tumors using selective glucocorticoid recept2023